anesthesia guidelines glp 1 GLP-1 agonists and risk: Assessment of gastric content using ultrasound The Impact of GLP-1 Receptor

This analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for GLP-1s

Lancet Neurol 2016;15:78-91

Vitamin D, magnesium, and iron deficiencies are frequently documented in patients on long-term GLP-1 therapy

how long it takes before half of the drug has left your body) and how the drug is absorbed in the body

While the science on allulose and blood glucose regulation is promising, more large-scale human studies are needed

Unlike Med+, Core+ does not include access to weight loss medication or clinicians